Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures

Clinical Trial ID NCT01526265

PubWeight™ 2.96‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01526265

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991 63.91
2 Actual causes of death in the United States, 2000. JAMA 2004 44.38
3 Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975 18.25
4 The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991 11.99
5 Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003 11.72
6 Qualitative data analysis for health services research: developing taxonomy, themes, and theory. Health Serv Res 2007 10.21
7 A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006 8.57
8 Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999 8.30
9 Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) 1999 7.04
10 Users' guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 2000 6.95
11 What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999 6.44
12 Constructing Grounded Theory: A practical guide through qualitative analysis Kathy Charmaz Constructing Grounded Theory: A practical guide through qualitative analysis Sage 224 £19.99 0761973532 0761973532 [Formula: see text]. Nurse Res 2006 6.34
13 A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009 6.08
14 Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep 2009 6.04
15 Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997 5.69
16 Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998 5.55
17 Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997 5.47
18 Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997 4.63
19 Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000 4.19
20 Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict Behav 1994 4.05
21 Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA 1994 3.83
22 Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. J Abnorm Psychol 2003 3.76
23 Priorities among recommended clinical preventive services. Am J Prev Med 2001 3.70
24 Tobacco addiction. Lancet 2008 3.65
25 Ethical incentives--not payment--for organ donation. N Engl J Med 2002 3.52
26 Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 1993 3.27
27 Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol 2000 3.24
28 Causal mediation analyses with rank preserving models. Biometrics 2007 2.67
29 Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome. Nicotine Tob Res 2001 2.52
30 P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood) 2009 2.49
31 Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med 2004 2.49
32 Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med 2015 2.39
33 Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology (Berl) 1999 2.30
34 Motivating and helping smokers to stop smoking. J Gen Intern Med 2003 2.22
35 Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend 2009 2.15
36 Adaptive designs for randomized trials in public health. Annu Rev Public Health 2009 2.15
37 On paying money to research subjects: 'due' and 'undue' inducements. IRB 1981 2.12
38 A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev 2006 1.93
39 Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 1994 1.88
40 Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction 2007 1.83
41 Regulated payments for living kidney donation: an empirical assessment of the ethical concerns. Ann Intern Med 2010 1.83
42 Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Arch Intern Med 1997 1.83
43 Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers. Exp Clin Psychopharmacol 2007 1.77
44 Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav 1998 1.68
45 Environmental tobacco smoke: health effects and policies to reduce exposure. Annu Rev Public Health 1997 1.67
46 State-specific smoking-attributable mortality and years of potential life lost--United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2009 1.41
47 International Symposium on Hodgkin's Disease. Session 6. Survival data and prognosis. Invited discussion: Forcing a sequential experiment to be balanced. Natl Cancer Inst Monogr 1973 1.38
48 Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. Nicotine Tob Res 2004 1.31
49 Random effects logistic models for analysing efficacy of a longitudinal randomized treatment with non-adherence. Stat Med 2006 1.12
50 Patients as mercenaries?: the ethics of using financial incentives in the war on unhealthy behaviors. Circ Cardiovasc Qual Outcomes 2009 1.09
51 Causal logistic models for non-compliance under randomized treatment with univariate binary response. Stat Med 2003 1.00
52 The SUCCESS project: the effect of program format and incentives on participation and cessation in worksite smoking cessation programs. Am J Public Health 2002 0.98
53 Young adult smoking: what factors differentiate ex-smokers, smoking cessation treatment seekers and nontreatment seekers? Addict Behav 2009 0.93
54 Preference-adaptive randomization in comparative effectiveness studies. Trials 2015 0.83
55 Intention-to-treat analyses in behavioral medicine randomized clinical trials. Int J Behav Med 2009 0.81
Next 100